Markets:

Overview

News

Currencies

International

Treasuries

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.540 +0.030 (+1.99%)

Streaming Delayed Price Updated: 11:30 AM EDT, Oct 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inhibikase Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Mid-Afternoon Market Update: Dow Tumbles 250 Points; Enochian Biosciences Shares Spike Higher

June 14, 2021

Toward the end of trading Monday, the Dow traded down 0.74% to 34,225.89 while the NASDAQ rose 0.45% to 14,132.55. The S&P also fell, dropping 0.27% to 4,236.03. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Day Market Update: Nasdaq Rises Over 50 Points; Washington Prime Group Shares Plunge

June 14, 2021

Midway through trading Monday, the Dow traded down 0.65% to 34,255.66 while the NASDAQ rose 0.41% to 14,126.79. The S&P also fell, dropping 0.23% to 4,237.53. The U.S. has the...

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session

June 14, 2021

Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request...

Via Benzinga

NASDAQ Co. Working Towards Advanced Treatments for Parkinson’s Disease and Cancer. Inhibikase Therapeutics (NASDAQ: IKT)

June 07, 2021

NASDAQ Company Diligently Working Towards Advanced Treatments for Parkinson’s Disease and Cancer: Inhibikase Therapeutics, Inc. (Stock Symbol: IKT)

Via EIN Presswire

Topics Intellectual Property

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying

May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks

May 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

44 Biggest Movers From Yesterday

April 23, 2021

Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares...

Via Benzinga

Topics Initial Public Offering

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

May 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex

April 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...

Via Benzinga

20 Stocks Moving in Wednesday's Pre-Market Session

April 07, 2021

Gainers UTime Limited (NASDAQ: UTME) rose 39.7% to $54.50 in pre-market trading. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share. SOS...

Via Benzinga

Topics Initial Public Offering

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.